Impact of α-spectrin mutations on the cytoskeleton and organelle organization in neurodegeneration

MSCA (Marie Skłodowska-Curie)HORIZON-TMA-MSCA-PF-EFID: 101107344
EC Contribution
€1,918
Consortium Size
1 orgs
Start Year
2023
Summary

Spectrins are an integral part of the submembranous cytoskeleton providing both mechanical scaffolding and organization hub for other proteins in metazoan cells. The importance of spectrins to neuronal health is demonstrated by their association with a wide range of human neurological disorders (spectrinopathies). Currently, more than forty mutations in the gene encoding non-erythroid -spectrin (SPTAN1) are associated with developmental and epileptic encephalopathies, hereditary motor neuropathy (HMN), spastic paraplegia (HSP), and ataxia. The underlying pathomechanisms remain largely unknown. In Drosophila, the highly conserved -spec homolog similarly plays an important role in the nervous system development, as well as in synapse formation, its function and maintenance. Interestingly, synaptic defects associated with loss of -spec can be suppressed via neuronal mitochondria repositioning. Conversely, increased levels of -spec rescue a range of neuronal phenotypes linked to actin-dependent mitochondrial dysfunction in an -synuclein neurodegeneration Drosophila model. These findings suggest that modulating the levels of -spec in neurons might have an important and understudied impact on tuning mitochondrial dynamics and preserving neuronal health. Thus, the goal of my MSCA proposal is to deepen our knowledge on how neuronal actin and spectrin cytoskeleton regulate mitochondria and assess mitochondrial dysfunction at the basis of -spectrinopathies, with a combined use of Drosophila as a model organism, and human iPSC-derived neurons as a platform to translate the findings to human neuronal health and disease. My project will provide insights on whether spectrin-associated mitochondrial dysfunction is a shared or specific feature for HMN, HSP and ataxia-associated spectrin mutants. I will deploy these findings to tailor a pharmacological treatment in the -spectrinopathy neuronal cellular models and develop a therapeutic strategy.

Consortium (1)

Project Results (7)

Source: CORDIS, the EU research results database.

Publications (4)
A heterozygous 9q34 deletion encompassing SPTAN1 as a cause of distal myopathy
European Journal of Human Genetics· 2025DOI
Liedewei Van de Vondel, Jonathan De Winter, Alice Monticelli, Natacha Camacho, Tine Deconinck, Katrien Janssens, Goedele Malfroid, Alicia Alonso-Jiménez, German Demidov, Steven Laurie, Willem De Ridder, Biljana Ermanoska, Vincent Timmerman, Jonathan Baets
Ageing Signatures and Disturbed Muscle Regeneration in Muscle Proteome of Inclusion Body Myositis
Journal of Cachexia, Sarcopenia and Muscle· 2025DOI
Geert M. de Vries, Bob Asselbergh, Alice Monticelli, Peter De Jonghe, Stuart Maudsley, Peter Y. K. Van Den Bergh, Anne Bigot, Jan L. De Bleecker, Biljana Ermanoska, Willem De Ridder, Jonathan Baets
Heterozygous loss-of-function variants in SPTAN1 cause an early childhood onset distal myopathy
Genetics in Medicine· 2025DOI
Jonathan De Winter, Liedewei Van de Vondel, Biljana Ermanoska, Alice Monticelli, Arnaud Isapof, Enzo Cohen, Tanya Stojkovic, Peter Hackman, Mridul Johari, Johanna Palmio, Megan A. Waldrop, Alayne P. Meyer, Stefan Nicolau, Kevin M. Flanigan, Ana Töpf, Jordi Diaz-Manera, Volker Straub, Cheryl Longman, Catherine A. McWilliam, Rotem Orbach, Sumit Verma, Regina Laine, Sandra Donkervoort, Carsten G. Bonnemann, Adriana Rebelo, Stephan Züchner, Tiffany Grider, Michael E. Shy, Isabelle Maystadt, Florence Demurger, Anita Cairns, Sarah Beecroft, Chiara Folland, Willem De Ridder, Gina Ravenscroft, Gisèle Bonne, Bjarne Udd, Jonathan Baets
Nonmuscle myosin II regulates presynaptic actin and neuronal mechanobiology in <i>Drosophila</i>
Journal of Cell Biology· 2025DOI
Biljana Ermanoska, Jonathan Baets, Avital A. Rodal
Deliverables (2)
Other Results (1)
Periodic Reporting for period 1 - SpecDroHuman (Impact of α-spectrin mutations on the cytoskeleton and organelle organization in neurodegeneration)